未登录

B

Beda Břicháček

the george washington university

H指数:27

被引数:3,304

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Maladaptive Trained Immunity Drives Persistent IL-6 Production and Enhanced TLR Responsiveness in Monocyte-Derived Macrophages from People Living with HIV

IF4.2

2026-02-040

OAAI

Increased Atherosclerosis in HIV-Infected Humanized Mice Is Caused by a Single Viral Protein, Nef

HIV感染者类人化小鼠中动脉粥样硬化的增加是由单一病毒蛋白Nef引起的

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2025-04-160

PRE

HIV-1 Nef is carried on the surface of extracellular vesicles

细胞外囊泡表面HIV-1携带Nef

JOURNAL OF EXTRACELLULAR VESICLES

IF14.5

2024-07-170

OA

Extracellular vesicles produced by HIV-1 Nef-expressing cells induce myelin impairment and oligodendrocyte damage in the mouse central nervous system

JOURNAL OF NEUROINFLAMMATION

IF10.1

2024-05-132

OAAI

Extracellular vesicles carrying HIV-1 Nef induce long-term hyperreactivity of myeloid cells

IF6.9

2022-11-0117

OAAI

Post Acute Infection Of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Leads To Systemic Inflammation And Podocyte Injury.

新型冠状病毒 (SARS-CoV-2) 急性感染后导致全身性炎症和足细胞损伤。

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2021-09-011

PRE

Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

坎格列净对2型糖尿病患者外周血CD34 ve内皮祖细胞 (EPC) 功能的影响

CARDIOVASCULAR DIABETOLOGY

IF10.6

2021-02-1329

OAAI

Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a randomized controlled trial

CARDIOVASCULAR DIABETOLOGY

IF10.6

2020-06-0325

OAAI

Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts (vol 11, e02956-19, 2020)

IF4.7

2020-04-281

OAAI

Inhibition of HIV Replication by Apolipoprotein A-I Binding Protein Targeting the Lipid Rafts

IF4.7

2020-02-2531

OAAI

Exosomes containing HIV protein Nef reorganize lipid rafts potentiating inflammatory response in bystander cells

IF4.9

2019-07-25102

OAAI

Interaction Between HIV-1 Nef and Calnexin: From Modeling to Small Molecule Inhibitors Reversing HIV-Induced Lipid Accumulation

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

IF7.4

2016-09-0126

OAAI

HIV-1 Protein Nef Inhibits Activity of ATP-binding Cassette Transporter A1 by Targeting Endoplasmic Reticulum Chaperone Calnexin

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2014-10-0136

OAAI

HIV-1 PROTEIN NEF IMPAIRS CELLULAR CHOLESTEROL EFFLUX BY DISRUPTING THE INTERACTION BETWEEN ABCA1 AND CALNEXIN

ATHEROSCLEROSIS

IF5.7

2014-08-010

PREAI

Prevention of vaginal SHIV transmission in macaques by a live recombinant Lactobacillus

MUCOSAL IMMUNOLOGY

IF7.6

2011-11-01152

OAAI

Response to The gatekeeper hypothesis challenged in a human cervico-vaginal tissue model for HIV-1 transmission

MUCOSAL IMMUNOLOGY

IF7.6

2011-01-010

OAAI

HIV-1 sexual transmission: early events of HIV-1 infection of human cervico-vaginal tissue in an optimized ex vivo model

MUCOSAL IMMUNOLOGY

IF7.6

2010-05-01133

OAAI

A New Class of Dual-Targeted Antivirals: Monophosphorylated Acyclovir Prodrug Derivatives Suppress Both Human Immunodeficiency Virus Type 1 and Herpes Simplex Virus Type 2

JOURNAL OF INFECTIOUS DISEASES

IF4.5

2010-02-1529

OAAI

Movements of HIV-Virions in Human Cervical Mucus

BIOMACROMOLECULES

IF5.4

2009-08-2849

OAAI

Mechanisms Associated with HIV-1 Resistance to Acyclovir by the V75I Mutation in Reverse Transcriptase

JOURNAL OF BIOLOGICAL CHEMISTRY

IF3.9

2009-08-0123

OAAI